Abstract:INTRODUCTION:X-ray crystallography plays an important role in structure-based drug design (SBDD), and accurate analysis of crystal structures of target macromolecules and macromolecule-ligand complexes is critical at all stages. However, whereas there has been significant progress in improving methods of structural biology, particularly in X-ray crystallography, corresponding progress in the development of computational methods (such as in silico high-throughput screening) is still on the horizon. Crystal structures can be overinterpreted and thus bias hypotheses and follow-up experiments. As in any experimental science, the models of macromolecular structures derived from X-ray diffraction data have their limitations, which need to be critically evaluated and well understood for structure-based drug discovery.AREAS COVERED:This review describes how the validity, accuracy and precision of a protein or nucleic acid structure determined by X-ray crystallography can be evaluated from three different perspectives: i) the nature of the diffraction experiment; ii) the interpretation of an electron density map; and iii) the interpretation of the structural model in terms of function and mechanism. The strategies to optimally exploit a macromolecular structure are also discussed in the context of 'Big Data' analysis, biochemical experimental design and structure-based drug discovery.EXPERT OPINION:Although X-ray crystallography is one of the most detailed 'microscopes' available today for examining macromolecular structures, the authors would like to re-emphasize that such structures are only simplified models of the target macromolecules. The authors also wish to reinforce the idea that a structure should not be thought of as a set of precise coordinates but rather as a framework for generating hypotheses to be explored. Numerous biochemical and biophysical experiments, including new diffraction experiments, can and should be performed to verify or falsify these hypotheses. X-ray crystallography will find its future application in drug discovery by the development of specific tools that would allow realistic interpretation of the outcome coordinates and/or support testing of these hypotheses.

Good reasons for structural biology

X-ray Crystallography over the Past Decade for Novel Drug Discovery - Where Are We Heading Next?

Cryo-electron Microscopy and X-ray Crystallography: Complementary Approaches to Structural Biology and Drug Discovery

Structural biology in the age of X-ray free-electron lasers and exascale computing

A Glimpse of Structural Biology through X-Ray Crystallography

Advances and challenges in time-resolved macromolecular crystallography

Protein Crystallography from the Perspective of Technology Developments

Advances, Challenges, and Opportunities in Structural Biology.

Current Status and Future Perspective of Cryo-electron Microscopy in Structural Biology

Membrane protein structure determination — The next generation

Overcoming challenges in structural biology with integrative approaches and nanobody-derived technologies

Structural Biology Revolution Led by Technical Breakthroughs in Cryo-electron Microscopy

The Future of Crystallography in Drug Discovery.

Building up complexity in structural biology studies

Structural biology in the Anthropocene epoch

Structure-guided drug discovery: back to the future

Structural biology is solved — now what?

Cryo-electron Microscopy for Structural Biology: Current Status and Future Perspectives

PROTEIN CRYSTALLOGRAPHY TECHNOLOGY——PAST, PRESENT AND FUTURE

Current Trends and Advancements in Crystallization and Single-Crystal Structural Analysis of Small Molecules

The Charm of Protein Crystals--structural Biology at a Glance in the International Year of Crystallography